Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-DA-23-001

Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional)

Closed on August 11, 2022.

Posted
July 8, 2021
Close date
August 11, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1 in first-year total cost, median $1.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 JRB-A (J2)]1

Most frequent institutions

  1. TEMPLE UNIV OF THE COMMONWEALTH1
Competing awards under RFA-DA-23-001 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse1R61DA058397-01ANDREWS, ALLISON MICHELLEJAIN, POOJARAMIREZ, SERVIO HEYBERTTEMPLE UNIV OF THE COMMONWEALTH, PA$1ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works